🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety, tolerability, and effi...
Status
Completed
Location
Collaborative Neuroscience Network
Start Date
2004-08
Trial ID
NCT00104273
Treatments Being Tested
The purpose of this study is to determine whether rasagiline is effective i...
Status
Terminated
Location
Department of Neurology and Palliative Care Klinikum der Universität München (Hospital of the University of Munich)
Start Date
2010-01
Trial ID
NCT01187888
Treatments Being Tested
When a patient with Parkinson's disease (PD) is initially treated with L-do...
Status
Completed
Location
Multiple Locations
Start Date
2010-07-14
Trial ID
NCT01155466
The objective of this study is to evaluate the efficacy, tolerability, and ...
Status
Completed
Location
CN002
Start Date
2011-11
Trial ID
NCT01736891
Treatments Being Tested
Sleep-wake disturbances (SWD) are frequent in Parkinson's disease (PD) and ...
Status
Terminated
Location
University Hospital, Neurology
Start Date
2011-09
Trial ID
NCT01178047
Treatments Being Tested
To test the clinical effect of rasagiline on subjects with MSA of the parki...
Status
Completed
Location
Teva Investigational Site 1004
Start Date
2009-12
Trial ID
NCT00977665
Treatments Being Tested
This is a Phase II, randomized, double blind, placebo controlled, parallel ...
Status
Completed
Location
Cleveland Clinic Lou Ruvo Center for Brain Health
Start Date
2015-05
Trial ID
NCT02359552
Treatments Being Tested
Title: Evaluation of the tolerance and acceptability of Rasagiline in the t...
Status
Terminated
Location
Multiple Locations
Start Date
2008-10
Trial ID
NCT01048229
Treatments Being Tested
This study will evaluate an oral fixed-dose, once daily product that combin...
Status
Completed
Location
P2B001 Site Birmingham
Start Date
2013-12
Trial ID
NCT01968460
This is a 24-week, multicenter, randomized, double-blind, placebo-controlle...
Status
Completed
Location
Teva Investigational Site 036
Start Date
2012-11
Trial ID
NCT01723228
Treatments Being Tested